| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Manjiri P Sune, Mona Sune, Pradeep Sune, Archana Dho. Prevalence of Retinopathy in Prediabetic Populations: A Systematic Review and Meta-Analysis. Cureus. vol 15. issue 11. 2024-01-01. PMID:38161917. |
among the leading causes of vision impairment and blindness globally, diabetic retinopathy (dr) is one of the most important causes. |
2024-01-01 |
2024-01-05 |
Not clear |
| Mohamed R Shoaib, Heba M Emara, Jun Zhao, Walid El-Shafai, Naglaa F Soliman, Ahmed S Mubarak, Osama A Omer, Fathi E Abd El-Samie, Hamada Esmaie. Deep learning innovations in diagnosing diabetic retinopathy: The potential of transfer learning and the DiaCNN model. Computers in biology and medicine. vol 169. 2023-12-30. PMID:38159396. |
this makes the early diagnosis of dr essential for effective treatment and prevention of eventual blindness. |
2023-12-30 |
2024-01-05 |
human |
| Mohamed R Shoaib, Heba M Emara, Jun Zhao, Walid El-Shafai, Naglaa F Soliman, Ahmed S Mubarak, Osama A Omer, Fathi E Abd El-Samie, Hamada Esmaie. Deep learning innovations in diagnosing diabetic retinopathy: The potential of transfer learning and the DiaCNN model. Computers in biology and medicine. vol 169. 2023-12-30. PMID:38159396. |
by facilitating earlier detection and more timely interventions, this approach stands poised to significantly reduce the incidence of blindness associated with dr, thus heralding a new era of improved patient outcomes. |
2023-12-30 |
2024-01-05 |
human |
| Mohamed R Shoaib, Heba M Emara, Jun Zhao, Walid El-Shafai, Naglaa F Soliman, Ahmed S Mubarak, Osama A Omer, Fathi E Abd El-Samie, Hamada Esmaie. Deep learning innovations in diagnosing diabetic retinopathy: The potential of transfer learning and the DiaCNN model. Computers in biology and medicine. vol 169. 2023-12-30. PMID:38159396. |
therefore, this work, through its novel approach and stellar results, not only pushes the boundaries of dr diagnostic accuracy but also promises a transformative impact in early detection and intervention, aiming to substantially diminish dr-induced blindness and champion enhanced patient care. |
2023-12-30 |
2024-01-05 |
human |
| Lan Wei, Jingjing Gao, Liangzhi Wang, Qianru Tao, Chao T. Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications. Therapeutic advances in endocrinology and metabolism. vol 14. 2023-12-28. PMID:38152659. |
similarly, dr involves retinal neovascularization and neurodegeneration as a result of chronic hyperglycemia and is the main cause of visual impairment and blindness. |
2023-12-28 |
2023-12-30 |
human |
| Chaoyang Zhang, Limin Gu, Hai Xie, Yan Liu, Peirong Huang, Jingting Zhang, Dawei Luo, Jingfa Zhan. Glucose transport, transporters and metabolism in diabetic retinopathy. Biochimica et biophysica acta. Molecular basis of disease. 2023-12-24. PMID:38142757. |
diabetic retinopathy (dr) is the most common reason for blindness in working-age individuals globally. |
2023-12-24 |
2023-12-27 |
Not clear |
| Kazuaki Ishihara, Koutarou Matsumot. Comparing the Robustness of ResNet, Swin-Transformer, and MLP-Mixer under Unique Distribution Shifts in Fundus Images. Bioengineering (Basel, Switzerland). vol 10. issue 12. 2023-12-23. PMID:38135974. |
diabetic retinopathy (dr) is the leading cause of visual impairment and blindness. |
2023-12-23 |
2023-12-25 |
Not clear |
| Ana Maria Dascalu, Adriana Georgescu, Andreea Cristina Costea, Laura Tribus, Alae El Youssoufi, Dragos Serban, Andreea Letitia Arsene, Daniela Stana, Cristina Alexandrescu, Bogdan Mihai Cristea, Denisa Tanasescu, Anca Bobirca, Crenguta Serboiu, Catalin Alius, Dan Georgian Brat. Association Between Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) With Diabetic Retinopathy in Type 2 Diabetic Patients. Cureus. vol 15. issue 11. 2023-12-13. PMID:38090430. |
diabetic retinopathy (dr) is one of the main causes of blindness worldwide, but an effective screening is challenging due to limited available retina specialists. |
2023-12-13 |
2023-12-17 |
Not clear |
| Abdulaziz A Barakat, Omar Mobarak, Haroon Ahmed Javaid, Mhd Rasheed Awad, Karam Hamweyah, Abderrahman Ouban, Selwa A F Al-Hazza. The application of artificial intelligence in diabetic retinopathy screening: a Saudi Arabian perspective. Frontiers in medicine. vol 10. 2023-12-11. PMID:38076258. |
diabetic retinopathy (dr) is the leading cause of preventable blindness in saudi arabia. |
2023-12-11 |
2023-12-17 |
Not clear |
| Fengtian Sun, Yuntong Sun, Xiaoling Wang, Junyan Zhu, Shenyuan Chen, Yifan Yu, Mengyao Zhu, Wenrong Xu, Hui Qia. Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1α/EZH2/PGC-1α pathway. Bioactive materials. vol 33. 2023-12-11. PMID:38076648. |
diabetic retinopathy (dr) is a leading cause of blindness worldwide with limited treatment options. |
2023-12-11 |
2023-12-17 |
mouse |
| Muayad S Albadrani, Ahmed M Alrehaili, Sultan H Alahmadi, Abdulqader A Aljazaeri, Osama F Almaghthawi, Saif N Alanazi, Osamah A Alrehail. Awareness of Diabetic Retinopathy Among Patients With Type 2 Diabetes Mellitus in Primary Healthcare Centers in Madinah, Saudi Arabia: A Cross-Sectional Study. Cureus. vol 15. issue 11. 2023-11-30. PMID:38033448. |
one of the most prevalent microvascular problems and the primary cause of blindness is diabetic retinopathy (dr), and a significant proportion of the population with diabetes eventually develop diabetes retinopathy. |
2023-11-30 |
2023-12-10 |
human |
| Todd McLaughlin, Grant Wang, Andy Medina, Jacob Perkins, Rhudwan Nihlawi, Don Seyfried, Zihua Hu, Joshua J Wang, Sarah X Zhan. Essential Role of XBP1 in Maintaining Photoreceptor Synaptic Integrity in Early Diabetic Retinopathy. Investigative ophthalmology & visual science. vol 64. issue 14. 2023-11-28. PMID:38015176. |
diabetic retinopathy (dr) is a leading cause of blindness in working-age adults characterized by retinal dysfunction and neurovascular degeneration. |
2023-11-28 |
2023-11-29 |
Not clear |
| Saket Y Maheshwari, Sunil Kumar, Arya Harshyt Sinha, Mayank Kuma. Diabetic Retinopathy: A Pharmacological Consideration. Cureus. vol 15. issue 10. 2023-11-13. PMID:37954772. |
one of the most significant reasons for the manifestation of new cases of complete blindness may be attributed to dr. |
2023-11-13 |
2023-11-20 |
human |
| Liu Li, Yu Jin, Jun Hua Wang, Sha Sha Wang, Fang Xiu Yua. Potency of teleophthalmology as a detection tool for diabetic retinopathy. Scientific reports. vol 13. issue 1. 2023-11-10. PMID:37949948. |
the purpose of this study was to use the results of ophthalmologists as the gold standard to evaluate the accuracy of community general practitioners' judgement and grading of dr to find a feasible and convenient dr screening method to reduce the risk of visual impairment and blindness in known diabetes patients. |
2023-11-10 |
2023-11-20 |
Not clear |
| Thokozani Zungu, Shaffi Mdala, Petros Kayange, Elizabeth Fernando, Halima Twabi, Arnold Jumbe, Johnstone Kumwenda, Adamson Muul. Uptake of diabetic retinopathy screening at a secondary level facility in Malawi. PLOS global public health. vol 3. issue 11. 2023-11-08. PMID:37939026. |
dr screening is a cost-effective intervention for preventing blindness from dr. we conducted a cross-sectional study to investigate the uptake and the predictors of uptake of annual dr screening in an opportunistic dr screening programme at a secondary-level diabetes clinic in southern malawi. |
2023-11-08 |
2023-11-20 |
human |
| Yanqiu Liu, Zifan Xu, Haohan Zheng, Jiahui Yang, Meili Wu, Qian Yang, Yan Wang, Tianyi Zong, Xusheng Yang, Tianhua Xie, Jiping Cai, Yong Yao, Xiaolu Wan. MiR-423-5p promotes Müller cell activation via targeting NGF signaling in diabetic retinopathy. Life sciences. 2023-11-04. PMID:37925140. |
diabetic retinopathy (dr) is a common microvascular complication of diabetes mellitus and one of the major causes of visual impairment and blindness in industrialized countries. |
2023-11-04 |
2023-11-08 |
mouse |
| Jufen Liu, Huijing Wang, Cuiting Huan. Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy Archives of physiology and biochemistry. 2023-11-03. PMID:37920998. |
exendin-4, a glp-1 receptor agonist, suppresses diabetic retinopathy diabetic retinopathy (dr) is a complication of diabetes and a leading cause of blindness in adults. |
2023-11-03 |
2023-11-08 |
rat |
| Posham Uppamma, Sweta Bhattachary. A multidomain bio-inspired feature extraction and selection model for diabetic retinopathy severity classification: an ensemble learning approach. Scientific reports. vol 13. issue 1. 2023-10-31. PMID:37903967. |
diabetes retinopathy (dr) is one of the leading causes of blindness globally. |
2023-10-31 |
2023-11-08 |
Not clear |
| Taif F Alqahtani, Rahaf Alqarehi, Oyoon M Mulla, Asayel T Alruwais, Shajn S Alsaadi, Hajar Algarni, Yaser M Elhams, Safa Alkalas. Knowledge, Attitude, and Practice Regarding Diabetic Retinopathy Screening and Eye Management Among Diabetics in Saudi Arabia. Cureus. vol 15. issue 9. 2023-10-31. PMID:37905261. |
background globally, one of the leading causes of blindness is diabetic retinopathy (dr). |
2023-10-31 |
2023-11-08 |
human |
| Pedro Romero-Aroca, Raquel Verges, Jordi Pascual-Fontanilles, Aida Valls, Josep Franch, Joan Barrot, Xavier Mundet, Alex La Torre, Antonio Moreno, Ramon Sagarra, Josep Basora, Eugeni Garcia-Curto, Marc Baget-Bernaldi. Effect of Lipids on Diabetic Retinopathy in a Large Cohort of Diabetic Patients after 10 Years of Follow-Up. Journal of clinical medicine. vol 12. issue 20. 2023-10-30. PMID:37892811. |
(1) background: diabetic retinopathy (dr) remains the leading cause of low vision and blindness in young adults of working age. |
2023-10-30 |
2023-11-08 |
Not clear |